215 related articles for article (PubMed ID: 12119402)
21. The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus.
Das D; Georgiadis MM
Structure; 2004 May; 12(5):819-29. PubMed ID: 15130474
[TBL] [Abstract][Full Text] [Related]
22. Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity.
Halvas EK; Svarovskaia ES; Pathak VK
J Virol; 2000 Jan; 74(1):312-9. PubMed ID: 10590119
[TBL] [Abstract][Full Text] [Related]
23. Amino acid substitutions away from the RNase H catalytic site increase the thermal stability of Moloney murine leukemia virus reverse transcriptase through RNase H inactivation.
Konishi A; Hisayoshi T; Yokokawa K; Barrioluengo V; Menéndez-Arias L; Yasukawa K
Biochem Biophys Res Commun; 2014 Nov; 454(2):269-74. PubMed ID: 25450388
[TBL] [Abstract][Full Text] [Related]
24. Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains.
Kögel D; Aboud M; Flügel RM
Virology; 1995 Oct; 213(1):97-108. PubMed ID: 7483284
[TBL] [Abstract][Full Text] [Related]
25. Mutating a conserved motif of the HIV-1 reverse transcriptase palm subdomain alters primer utilization.
Ghosh M; Williams J; Powell MD; Levin JG; Le Grice SF
Biochemistry; 1997 May; 36(19):5758-68. PubMed ID: 9153416
[TBL] [Abstract][Full Text] [Related]
26. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
Lim D; Orlova M; Goff SP
J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
[TBL] [Abstract][Full Text] [Related]
27. Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activity.
Goobar-Larsson L; Bäckbro K; Unge T; Bhikhabhai R; Vrang L; Zhang H; Orvell C; Strandberg B; Oberg B
Virology; 1993 Oct; 196(2):731-8. PubMed ID: 7690504
[TBL] [Abstract][Full Text] [Related]
28. Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases.
Loya S; Rudi A; Kashman Y; Hizi A
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):85-92. PubMed ID: 10548537
[TBL] [Abstract][Full Text] [Related]
29. Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract.
Dash C; Rausch JW; Le Grice SF
Nucleic Acids Res; 2004; 32(4):1539-47. PubMed ID: 15004241
[TBL] [Abstract][Full Text] [Related]
30. DNA polymerization by the reverse transcriptase of the human L1 retrotransposon on its own template in vitro.
Piskareva O; Schmatchenko V
FEBS Lett; 2006 Jan; 580(2):661-8. PubMed ID: 16412437
[TBL] [Abstract][Full Text] [Related]
31. Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching.
Svarovskaia ES; Delviks KA; Hwang CK; Pathak VK
J Virol; 2000 Aug; 74(15):7171-8. PubMed ID: 10888659
[TBL] [Abstract][Full Text] [Related]
32. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities.
Post K; Guo J; Kalman E; Uchida T; Crouch RJ; Levin JG
Biochemistry; 1993 Jun; 32(21):5508-17. PubMed ID: 7684924
[TBL] [Abstract][Full Text] [Related]
33. Defects in primer-template binding, processive DNA synthesis, and RNase H activity associated with chimeric reverse transcriptases having the murine leukemia virus polymerase domain joined to Escherichia coli RNase H.
Guo J; Wu W; Yuan ZY; Post K; Crouch RJ; Levin JG
Biochemistry; 1995 Apr; 34(15):5018-29. PubMed ID: 7536033
[TBL] [Abstract][Full Text] [Related]
34. Involvement of C-terminal structural elements of equine infectious anemia virus reverse transcriptase in DNA polymerase and ribonuclease H activities.
Rausch JW; Arts EJ; Wöhrl BM; Le Grice SF
J Mol Biol; 1996 Apr; 257(3):500-11. PubMed ID: 8648620
[TBL] [Abstract][Full Text] [Related]
35. Increased thermostability and fidelity of DNA synthesis of wild-type and mutant HIV-1 group O reverse transcriptases.
Alvarez M; Matamoros T; Menéndez-Arias L
J Mol Biol; 2009 Oct; 392(4):872-84. PubMed ID: 19651140
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K
Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458
[TBL] [Abstract][Full Text] [Related]
37. Properties of strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase: mechanistic implications.
Whiting SH; Champoux JJ
J Mol Biol; 1998 May; 278(3):559-77. PubMed ID: 9600839
[TBL] [Abstract][Full Text] [Related]
38. Sequence and comparative structural analysis of the murine leukaemia virus amphotropic strain 4070A RNase H domain.
Ey PL; Freeman NL; Bela B; Haese PM; Li P; McInnes JL
Arch Virol; 1999; 144(11):2185-99. PubMed ID: 10603172
[TBL] [Abstract][Full Text] [Related]
39. Gln(84) of moloney murine leukemia virus reverse transcriptase regulates the incorporation rates of ribonucleotides and deoxyribonucleotides.
Liu S; Goff SP; Gao G
FEBS Lett; 2006 Feb; 580(5):1497-501. PubMed ID: 16466720
[TBL] [Abstract][Full Text] [Related]
40. Cis-acting elements required for strong stop acceptor template selection during Moloney murine leukemia virus reverse transcription.
Topping R; Demoitie MA; Shin NH; Telesnitsky A
J Mol Biol; 1998 Aug; 281(1):1-15. PubMed ID: 9680471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
